| Literature DB >> 26872321 |
Qiao-Qiao Tao1, Ke Ma1, Li Bao1, Kai Wang1, Jun-Jie Han1, Wen-Zhao Wang1, Jin-Xia Zhang2, Chen-Yang Huang2, Hong-Wei Liu1.
Abstract
One new perhydrobenzannulated 5,5-spiroketal sesquiterpene, pleurospiroketal F (1), as well as six new modified bisabolene sesquiterpenes pleurotins A-F (2-7) were isolated from solid-state fermentation of Pleurotus citrinopileatus. The structures of compounds 1-7 were determined by NMR and MS spectroscopic analysis. The absolute configuration of 1 was determined by X-ray diffraction analysis, while the absolute configurations of 3-7 were assigned using the in situ dimolybdenum circular dichroism method and circular dichroism data comparison. Protein tyrosine phosphatase 1B plays a crucial role as a negative regulator of the insulin-dependent signal cascades. Therefore, the protein tyrosine phosphatase 1B inhibitor can be used for treating type 2 diabetes mellitus and obesity. Compounds 2 and 6 showed moderate inhibitory effects on protein tyrosine phosphatase 1B with IC50 s of 32.1 µM and 30.5 µM, respectively. The kinetic study confirmed compound 2 to be a noncompetitive inhibitor. Compounds 1-7 did not show cytotoxic activity against cancer cell lines (IC50 > 50 µM). Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26872321 DOI: 10.1055/s-0041-111629
Source DB: PubMed Journal: Planta Med ISSN: 0032-0943 Impact factor: 3.352